[ENSC] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[ENSC] Ensysce Biosciences, Inc.
Announcement Date
14-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -30.26%
YoY- -36.55%
Quarter Report
ENSC's Result
ENSC's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 182 306 515 435 490 790 1,433 -74.76%
PBT -1,968 -3,117 -3,504 -2,691 -2,239 -2,192 -5,478 -49.49%
Tax 0 -0 360 6 -3 -364 -2,912 -
NP -1,968 -3,116 -3,504 -2,690 -2,236 -1,828 -2,566 -16.22%
Tax Rate - - - - - - - -
Total Cost 2,150 3,422 4,019 3,125 2,726 2,618 4,000 -33.91%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -1,082.41 -1,019.39 -680.40 -617.75 -455.88 -231.53 -179.01 232.26%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.22 -0.55 -1.55 -0.87 -0.98 -1.73 -8.46 -91.24%
EPS Diluted -0.22 -0.55 -1.55 -0.87 -0.98 -1.73 -8.46 -91.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.